GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Makers Laboratories Ltd (BOM:506919) » Definitions » Price-to-Owner-Earnings

Makers Laboratories (BOM:506919) Price-to-Owner-Earnings : (As of Jun. 03, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Makers Laboratories Price-to-Owner-Earnings?

As of today (2024-06-03), Makers Laboratories's share price is ₹124.85. Makers Laboratories does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Makers Laboratories's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Makers Laboratories was 32.14. The lowest was 12.75. And the median was 19.24.


BOM:506919's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.88
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-03), Makers Laboratories's share price is ₹124.85. Makers Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-10.61. Therefore, Makers Laboratories's PE Ratio for today is At Loss.

As of today (2024-06-03), Makers Laboratories's share price is ₹124.85. Makers Laboratories's EPS without NRI for the trailing twelve months (TTM) ended in was ₹-10.61. Therefore, Makers Laboratories's PE Ratio without NRI for today is At Loss.

During the past 13 years, Makers Laboratories's highest PE Ratio without NRI was 110.60. The lowest was 0.00. And the median was 16.95.


Makers Laboratories Price-to-Owner-Earnings Historical Data

The historical data trend for Makers Laboratories's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Makers Laboratories Price-to-Owner-Earnings Chart

Makers Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 16.59 - -

Makers Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Makers Laboratories's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Makers Laboratories's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Makers Laboratories's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Makers Laboratories's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Makers Laboratories's Price-to-Owner-Earnings falls into.



Makers Laboratories Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Makers Laboratories's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=124.85/-15.36
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Makers Laboratories  (BOM:506919) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Makers Laboratories Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Makers Laboratories's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Makers Laboratories (BOM:506919) Business Description

Traded in Other Exchanges
N/A
Address
54-D, Kandivli Industrial Estate, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti cough Range), and Exylin (Amoxycillin range) among others.

Makers Laboratories (BOM:506919) Headlines

No Headlines